Shenglan Shang

531 total citations
19 papers, 223 citations indexed

About

Shenglan Shang is a scholar working on Immunology, Pharmacology and Epidemiology. According to data from OpenAlex, Shenglan Shang has authored 19 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Pharmacology and 4 papers in Epidemiology. Recurrent topics in Shenglan Shang's work include Drug Transport and Resistance Mechanisms (2 papers), Erythrocyte Function and Pathophysiology (2 papers) and Vitamin D Research Studies (2 papers). Shenglan Shang is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), Erythrocyte Function and Pathophysiology (2 papers) and Vitamin D Research Studies (2 papers). Shenglan Shang collaborates with scholars based in China, India and Philippines. Shenglan Shang's co-authors include Hong Zhou, Mei Kuang, Jiang Zheng, Rongxin Qin, Yanyan Cen, Chao Liu, Xia Kang, Xichun Pan, Rongchen Shi and Ruixiang Liu and has published in prestigious journals such as Cancer Research, British Journal of Pharmacology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Shenglan Shang

18 papers receiving 220 citations

Peers

Shenglan Shang
Comparison fields: 5 of 68
  • Immunology 72
  • Molecular Biology 55
  • Epidemiology 55
  • Cancer Research 27
  • Pharmacology 27
Replace Minghua Cao with:
Minghua Cao China
Weimin Jiang China
Yanfeng Ma China
Dadong Liu China
Shang-Jyh Kao Taiwan
Charles D Smart United States
Yan Xing China
Shao-Mei Huang Taiwan
Minghua Cao China View profile →
Citations per field, relative to Shenglan Shang
Shenglan Shang · 1×
Citations per year, relative to Shenglan Shang
Shenglan Shang · 1×

Countries citing papers authored by Shenglan Shang

Since Specialization
Citations

This map shows the geographic impact of Shenglan Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Shang more than expected).

Fields of papers citing papers by Shenglan Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglan Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Shang. The network helps show where Shenglan Shang may publish in the future.

Co-authorship network of co-authors of Shenglan Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglan Shang. A scholar is included among the top collaborators of Shenglan Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglan Shang. Shenglan Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
# Work Indexed citations
1 2
2 2
3 1
4 1
5 5
6 3
7 4
8 6
9 1
10 0
11 26
12 29
13 12
14 15
15 49
16 33
17 8
18 5
19 21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026